By Josh White
Date: Monday 01 Sep 2025
(Sharecast News) - Crism Therapeutics said on Monday that it has received both regulatory clearance from the UK Medicines and Healthcare products Regulatory Agency (MHRA) and ethical approval from a UK Research Ethics Committee to begin its registration-grade phase two trial of irinotecan-ChemoSeed in glioblastoma patients.
By Josh White
Date: Tuesday 26 Aug 2025
(Sharecast News) - Crism Therapeutics used its annual general meeting on Tuesday to highlight progress on its ChemoSeed drug delivery platform as it advances towards key clinical milestones.
By Josh White
Date: Wednesday 13 Apr 2022
(Sharecast News) - Russia-focussed nickel-copper-sulphide explorer and developer Amur Minerals updated the market on the effect of sanctions on Wednesday, having been "continuously reviewing" those put in place by the European Union, the UK and the United States since Russia's invasion of Ukraine.
Currency | UK Pounds |
Share Price | 10.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 18.00 |
52 Week Low | 10.13 |
Volume | 13,662 |
Shares Issued | 39.96m |
Market Cap | £4.20m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
Latest | Previous | |
---|---|---|
Special | Interim | |
Ex-Div | 01-Jun-23 | n/a |
Paid | 14-Jun-23 | n/a |
Amount | 1.80p | 0.000¢ |
Time | Volume / Share Price |
10:57 | 9,054 @ 10.13p |
08:50 | 90 @ 11.00p |
08:01 | 4,518 @ 10.80p |
CEO | Andrew James Webb |
You are here: research